Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study

Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)

(2012) Laura Biganzoli et al.   LANCET ONCOLOGY

Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors

(2011) C. Serrano et al.   ANNALS OF ONCOLOGY

Infused Therapy and Survival in Older Patients Diagnosed with Metastatic Breast Cancer who Received Trastuzumab

(2011) Robert I. Griffiths et al.   CANCER INVESTIGATION

Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHER

(2011) A. M. Brufsky et al.   CLINICAL CANCER RESEARCH

Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer

(2011) Luigi Tarantini et al.   JOURNAL OF CARDIAC FAILURE

EORTC elderly task force position paper: Approach to the older cancer patient

(2010) A.G. Pallis et al.   EUROPEAN JOURNAL OF CANCER

Trastuzumab treatment in patients with breast cancer and metastatic CNS disease

(2009) T. Pienkowski et al.   ANNALS OF ONCOLOGY

Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

(2009) Hyman B. Muss et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial

(2008) Edith A. Perez et al.   JOURNAL OF CLINICAL ONCOLOGY